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Harvard School of Public Health which dephosphorylates cytoplasmic NFATs and en-
ables them to translocate to the nucleus and thereby†Department of Medicine
Harvard Medical School assist in gene transcription (Flanagan et al., 1991).
Given the varied expression patterns of the NFATs,Boston, Massachusetts 02115
understanding the roles of NFAT in immunity depends
in part upon elucidating the functions of the individual
NFAT family members. Studies of animals and/or lym-
Summary phoid chimeras deficient in various members have re-
vealed a diverse and unique array of phenotypes.
NFAT transcription factors play critical roles in gene NFATc1-deficient lymphocytes demonstrated impaired
transcription during immune responses. To investi- proliferative and Th2-like responses (Ranger et al.,
gate further the two most prominent NFAT family 1998b; Yoshida et al., 1998), while NFATc2-deficient ani-
members, NFATc1 and NFATc2, we generated mice mals displayed modestly enhanced immune responses
bearing lymphoid systems devoid of both. Doubly defi- with Th2-like characteristics (Hodge et al., 1996; Xan-
cient T cells displayed cell surface markers of activa- thoudakis et al., 1996; Kiani et al., 1997; Schuh et al.,
tion yet were significantly deficient in the development 1998), and NFATc3 deficiency caused increased apo-
of multiple effector functions, including Th cytokine ptosis of thymocytes and hyperactivation of peripheral
production, surface effector molecule expression, and T cells (Oukka et al., 1998). These findings suggest that
cytolytic activity. Nevertheless, doubly deficient B NFATc1 might provide principally a proliferative func-
cells were hyperactivated, as evidenced by extremely tion, while NFATc2 and NFATc3 provide repressive func-
elevated serum IgG1 and IgE, as well as plasma cell tions in the immune system. Accordingly, NFATc1 is
expansion and infiltration of end organs. Thus, in T rapidly induced, while NFATc2 and NFATc3 are rapidly
cells, NFATc1 and NFATc2 are dispensable for inflam- repressed, by anti-CD3-mediated stimulation of T cell
matory reactivity but are required for effector differen- clones (Ranger et al., 1998c). In fact, animals deficient
tiation, while in B cells, NFATs regulate both normal in both NFATc2 and NFATc3 demonstrated significant
homeostasis and differentiation. defects in lymphocyte apoptosis, developing a profound
lymphadenopathy and Th2-predominant syndrome in-
cluding allergic blepharitis and pneumonitis (Ranger etIntroduction
al., 1998c).
The majority of NFAT proteins in lymphocytes, how-Nuclear factor of activated T cells (NFAT) transcription
ever, consists of NFATc1 and NFATc2 (Rao et al., 1997),factors play a central role in the regulation of gene tran-
and further understanding of the roles of and interac-scription, but the precise effector mechanisms by which
tions between these two NFAT family members has re-they regulate cellular responses remain incompletely
mained of interest. To address such issues, mice whoseunderstood. Most studied in T cells, NFAT has been
lymphocytes were deficient in both transcription factorsimplicated in the regulation of multiple cytokines and
were generated by fetal liver chimerization in recombi-other regulatory molecules, including interleukin-2 (IL-2),
nase activating gene-2 (RAG-2)-deficient hosts. TheseIL-3, IL-4, IL-5, IL-6, IL-8, GM-CSF, interferon (IFN)-g,
chimeric animals displayed significantly impaired pro-tumor necrosis factor (TNF)-a, CD40 ligand (CD154), and
duction of T cell–dependent effector functions yet devel-CD95 ligand (FasL); yet multiple further studies have
oped significant B cell activation. Such findings empha-implicated NFAT proteins in the immune responses of
size the importance of the NFAT transcription factors inB lymphocytes, NK cells, macrophages, mast cells, and
the balanced regulation of the immune response.eosinophils, among others (Rao et al., 1997). Indeed,
the NFAT family includes at least four calcium-regulated
Resultsmembers, NFATc1 (NFATc, NFAT2), NFATc2 (NFATp,
NFAT1), NFATc3 (NFAT4, NFATx), and NFATc4 (NFAT3),
Generation of Animals Bearing Lymphoid Systemseach of which displays a unique tissue pattern of expres-
Lacking NFATc1 and NFATc2sion and plays a differential role in gene transcription.
Irradiated RAG-2-deficient hosts were successfully re-Despite their differences, however, the NFATs share a
populated with NFATc12/2 NFATc22/2 fetal liver cells.similar mechanism of activation, in which signals medi-
Donor-derived lymphocytes and immunoglobulins were
detectable in the peripheral blood as early as 3 weeks
‡ To whom correspondence should be addressed (e-mail: lglimche@ after repopulation by flow cytometric analysis and
hsph.harvard.edu). ELISA, respectively (Figure 1 and data not shown). While§ Present address: Department of Developmental Biology, Stanford
fetal livers singly deficient in NFATc1 demonstrate de-University School of Medicine, Stanford, California 94305.
layed lymphoid repopulation, reconstitution in doublyk Present address: Department of Cancer Immunology and AIDS,
Dana-Farber Cancer Institute, Boston, Massachusetts 02115. deficient NFATc1/NFATc2 (DKO) chimeras was compa-
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naive precursor T cells (Figure 2C and data not shown).
Of all cytokines tested, IL-5, while also significantly di-
minished, was produced by DKO T cells in highest levels
relative to wild type. In addition, DKO T cells were im-
paired in the induction of CD154 (CD40 ligand) and CD95
(Fas) ligand expression (Figure 2D) and performed
poorly in assays of allogenic cytotoxicity, even in the
presence of exogenous IL-2 (Figure 2E). These findings
demonstrate that, while T cell inflammatory respon-
siveness, as indicated by TCR-mediated proliferation
and activation marker expression, may be intact or even
exaggerated in the absence of NFATc1 and NFATc2,
T cell effector functions, as evidenced by cytotoxicity,Figure 1. Reconstitution of Irradiated RAG-2-Deficient BALB/c
Hosts by Fetal Liver Cells functional receptor expression, and Th cytokine produc-
Shown are the results for two animals, each representative of four tion, require both NFAT family members.
serially studied animals. T and B cell populations were determined
as percentage of peripheral blood lymphocytes (PBL) at the times Hyperactivation of DKO B Cellsindicated via flow cytometry for CD3 or IgM, respectively.
Serum immunoglobulin analysis of DKO chimeras re-
vealed significantly increased levels of IgG1 and IgE
immunoglobulins, isotypes typically associated withrable to wild-type controls, with the initial appearance
Th2-like immune responses (Table 2). Furthermore,of predominantly B cells in the peripheral circulation,
whole splenocytes from DKO chimeras spontaneouslyfollowed by T cells within 2–4 weeks (Ranger et al.,
produced immunoglobulins of these two isotypes and1998b, Figure 1 and data not shown).
demonstrated exaggerated responses to B cell activa-
tors, including CD40 or B cell receptor engagement and/Inflammatory Responsiveness but Impaired Effector
or IL-4 stimulation (Figure 3A). DKO splenocytes sponta-Responses in DKO T Cells
neously produced significant titers of immunoglobulin,Peripheral lymphoid organs were somewhat enlarged in
even in the absence of activators. These findings clearlyDKO chimeras, but flow cytometric analyses revealed
demonstrate the presence of B cell hyperactivation ingrossly normal proportions of T cells (CD41, CD81, ab,
DKO chimeras.and gd), IgM/IgD-bearing B cells, and NK populations
Given the severe impairment in IL-4 production andin the thymus and peripheral lymphoid organs (Table 1
CD154 expression by DKO T cells, such results furtherand data not shown). T cells from DKO chimeras were
suggested that B cell activation in these animals waspurified and analyzed for T cell effector functions (Figure
autonomous. Indeed, purified B cell populations from2). DKO T cells were capable of reasonable proliferative
DKO animals were spontaneously activated to produceresponses induced by plate-bound anti-CD3 and anti-
IgG1 and IgE; although the presence of T cells enhancedCD28 (Figure 2A) and interestingly displayed markers of
the production of Ig by DKO B cells, they were clearlyT cell activation such as upregulated expression of CD69
not required, and B cell activity was independent ofand downregulated expression of CD62L and CD45RB
classical T cell–dependent requirements, such as CD154,(Figure 2B). Such findings demonstrate grossly pre-
IL-4, and IL-13 (Figure 3B). In addition, treatment of twoserved TCR-mediated proliferative capacity in the ab-
DKO chimeric animals in vivo with neutralizing antibodysence of NFAT yet further suggest that T cells are spon-
to IL-4 failed to abrogate the hypergammaglobulinemiataneously activated in vivo in the absence of NFATc1
G1 and E (Table 3). Such findings argue strongly in DKOand NFATc2.
chimeras for the presence of autonomous, T cell–On the other hand, DKO T cells were severely impaired
independent B cell activation, which may be enhancedin the production of several T cell–derived cytokines,
by IL-4-independent, CD154-independent T cell factors.including IL-2, IFN-g, and IL-4 (Figure 2C). These cyto-
Histological examination of organs from DKO chimerickines, as well as IL-10, GM-CSF, and TNF-a, were unde-
animals revealed pathological plasma cell infiltrates, es-tectable upon primary or secondary stimulation under
pecially of the lung, kidney, and liver (Figure 4A, panelsTh1 or Th2 conditions, using bulk CD41 or CD41CD62Lhi
a–c compared to d–f). These infiltrates bore the typical
histopathological appearance of plasma cells, staining
appropriately with methyl-pyronin green (Figure 4B).
Table 1. Lymphoid Organ Populations in DKO Chimeras
Such findings strongly resemble the end organ infiltra-
Donor Age (wk) Thymus Spleen Lymph Nodes tion in the human malignancy multiple myeloma (Bataille
and Harousseau, 1997), but DKO B cell hyperactivationWT 6 6.9 49.6 17.6
appeared to reflect a polyclonal defect, as illustrated by10 ND 52.0 13.0
16 9.4 58.4 12.2 the presence of significant titers of IgE of both kappa
18 ND 90.2 22.6 and lambda light chains (Figure 3C), and B cell tolerance
DKO 6 6.9 73.0 15.2 and regulation by apoptosis appeared largely intact in
10 ND 113.5 28.5
these animals, as demonstrated by the absence of anti-16 3.1 137.0 24.6
nuclear autoantibodies or defects in IgM-mediated18 ND 123.8 82.6
apoptosis (data not shown). Therefore, while NFATs do
Numbers indicate millions of cells. ND, not determined.
not appear to play a critical role in the regulation of
T and B Cells without NFATc1 and NFATc2
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Figure 2. T Cell Activation and Effector Function in the Absence of NFATc1 and NFATc2
(A) T cells from wild-type (WT) or NFATc1/NFATc2-deficient (DKO) fetal liver chimeras were assayed for CD3-mediated proliferative capacity.
Standard error for each experimental point was within 10,000 cpm.
(B) Activation markers on CD41 T cells were assayed by three-color flow cytometry. CD41 gated T cells are shown, with numbers indicating
percentage of cells in each respective quadrant.
(C) T cells were assayed for effector cytokine production. IL-2 and IFN-g were assayed during primary stimulation, while IL-4 and IL-5 were
assayed upon secondary stimulation under Th2-skewing conditions. T cell populations shown were magnetically purified CD41 splenocytes;
similar results were obtained with flow cytometry–sorted CD41CD62Lhi cells or magnetically B220-depleted populations (not shown). Shown
are results from supernatants harvested 48 hr after stimulation. An asterisk (*) indicates undetectable levels (,0.2 pg/mL for IL-2 and ,0.5
pg/mL for IL-4).
(D) CD154 (CD40 ligand) and CD95 (Fas) ligand expression was assessed on DKO T cells. CD154 was induced in splenocytes with concanavalin
A for 6 hr, and expression was analyzed by dual-color flow cytometry on CD41 T cells. CD95 ligand was induced in splenocytes secondarily
stimulated with anti-CD3 and anti-CD28 for 6 hr, and expression was analyzed by dual color flow cytometry on CD41 T cells.
(E) Allogeneic cytotoxicity was assessed by DKO T cells (H-2d) against the EL4 tumor line (H-2b). Cytotoxic lymphocyte precursors were
stimulated from splenocytes with concanavalin A in the presence or absence of human IL-2 for 5 days and then incubated with EL4 target
cells in the ratios indicated. Percent lysis was determined by lactate dehydrogenase release. Standard error for each experimental point was
less than 5% lysis. All results (A–E) are representative of three animals tested.
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Table 2. Serum Immunoglobulin Levels in DKO Chimeras
Donor Age (wk) IgM IgA IgE IgG1 IgG2a IgG2b IgG3
WT 10 365 50 5.6 60 180 100 245
22 700 325 1.4 65 130 150 160
26 305 275 0.8 55 205 145 160
DKO 10 ND 220 3100 500 160 190 62
10 360 40 870 400 80 180 204
10 350 100 2900 900 175 170 100
11 320 70 280 530 41 195 85
11 345 130 1000 1100 285 105 340
11 280 55 750 355 115 110 105
22 125 70 890 330 44 90 145
Age indicates time in weeks postreconstitution. Sera were assayed by ELISA. Values all indicate serum concentrations in mg/mL. ND, not
done.
apoptosis or tolerance in B cells, these findings demon- the MAP kinase p38 (Gomez del Arco et al., 2000), to
name a few, the majority of NFAT activation likely occursstrate that NFATc1 and NFATc2 are essential for the
maintenance of B cell homeostasis. via Ca21 mobilization and the activation of calcineurin
(Kiani et al., 2000; Zhang and Samelson, 2000). The pres-
ent findings may therefore identify Ca21-dependentDiscussion
NFAT activity as critical for TCR-mediated T cell effector
functions but otherwise indicate that NFATs are dis-In this study, the roles of NFATc1 and NFATc2 in T
and B cells were examined in RAG-2-deficient fetal liver pensable for other TCR-dependent responses, like pro-
liferation, which may rely more heavily upon other path-chimeras. Doubly deficient T cells remained capable of
TCR-mediated activation, as demonstrated by prolifera- ways such as Ras/MAPK.
As an important contrast to the present NFATc1/tive capacity, but significantly impaired effector func-
tions, as demonstrated by cytokine production, effector NFATc2-deficient chimeras, NFATc2/NFATc3-deficient
animals developed a profound Th2-predominant syn-molecule expression, and allogeneic cytotoxicity. In
contrast, doubly deficient B cells displayed signs of hy- drome involving blepharitis and allergic pneumonitis as-
sociated with dramatic increases in serum IgG1 and IgEperactivation and hyperdifferentiation, as evidenced by
significantly elevated titers of some serum immunoglob- levels (Ranger et al., 1998c). T cells from these latter
animals were severely skewed toward a Th2 phenotype,ulins and expanded populations of plasma cells. To-
gether, these observations indicate that NFATc1 and with significantly elevated production of IL-4, IL-5, IL-6,
and IL-10 but diminished production of IL-2, IFN-g, andNFATc2 are necessary for the completion of T cell differ-
entiation and the maintenance of B cell homeostasis TNF-a. On the other hand, NFATc1/NFATc2-deficient T
cells were unable to generate significant levels of anybut not in the activation of naive T cells or B cells.
These results further characterize NFAT as a tran- cytokine, Th1 or Th2, suggesting a global deficit in T
cell differentiation and perhaps T cell effector functionscription factor family that plays a critical role in the
regulation of lymphocyte effector differentiation, as op- in general. As such, it is tempting to speculate that
NFATc2 participates with NFATc3 in the downregulationposed to activation. A similar dichotomy has been de-
scribed for several protein kinases, such as the c-Jun of Th2-dependent cytokine responses but participates
with NFATc1 in the initiation and/or maintenance ofamino-terminal kinases Jnk1 and Jnk2, which were
found to be required for T cell effector functions but not lymphoid cell effector functions in general. Still, given
the fairly modest findings in animals with single NFATc1activation (Dong et al., 2000), or Janus kinase 3 (Jak3),
which was downregulatory for T cell activation but was or NFATc2 deficiencies (Hodge et al., 1996; Xanthou-
dakis et al., 1996; Kiani et al., 1997; Ranger et al., 1998b;nonetheless required for proper T cell development (No-
saka et al., 1995; Park et al., 1995; Thomis et al., 1995). Schuh et al., 1998; Yoshida et al., 1998), the functions
of NFATc1 and NFATc2 may be largely redundant in theAccordingly, NFATc2 has been implicated in the Jak3
pathway (Thomis et al., 1999) and NFATc1 has been regulation of most effector cytokines, as suggested by
previous work involving the effects of a dominant-nega-implicated in the Jnk pathway (Dong et al., 1998; Chow
et al., 2000). These kinases, however, do not obviously tive NFAT mutant on IL-2 expression (Chow et al., 1999)
and of an NFAT-inhibitory peptide on IL-2, IL-13, IL-3,represent the entire NFAT pathway, since, unlike the
NFATc1/NFATc2-deficient animals described here, Jnk1/ TNF-a, GM-CSF, and MIP-1a expression (Aramburu et
al., 1999). The specific regulatory roles of each protein,Jnk2-deficient T cells produced increased Th2 cyto-
kines, suggesting that they play a predominant role in however, likely differ somewhat. Accordingly, another
attractive hypothesis involves the promotion of a Th1-Th1 activation (Dong et al., 2000), and Jak3 deficiency
causes severe combined immunodeficiency (Nosaka et like response by NFATc2 in an effort to downregulate
otherwise Th2-like responses: NFATc2-deficient animalsal., 1995; Russell et al., 1995; Thomis et al., 1995). In-
deed, while a large number of signaling molecules has displayed dysregulated expression of IL-4 but diminished
expression of IFN-g (Hodge et al., 1996; Xanthoudakisbeen implicated in NFAT activation following TCR en-
gagement, including Itk (Fowell et al., 1999), SLP-76 and et al., 1996; Kiani et al., 1997), while NFATc1-deficient
T cells produced less IL-4 and IL-6 but largely normalGrpL (Law et al., 1999), Gsk-3 (Beals et al., 1997), and
T and B Cells without NFATc1 and NFATc2
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Figure 3. B Cell Activation in DKO Chimeras
(A) Whole splenocytes from DKO or WT chimeras were assayed for immunoglobulin production in vitro under the conditions indicated. IgG1
and IgE production in supernatants were assayed by ELISA. An asterisk (*) indicates that the IgE level was undetectable (,1 ng/mL).
(B) T cell dependency of B cell Ig production was assayed in DKO chimeras. T and B cell populations were purified magnetically by CD3 and
B220, respectively, and then incubated under the conditions shown for 48 hr. CsA indicates the presence of cyclosporin A, 10 mg/mL.
(C) Polyclonality of the IgE response was assayed by light chain–specific isotyping on serum IgEs from DKO (NFATc1/c2) chimeras. For comparison,
several sera from animals deficient in both NFATc2 and NFATc3 were assayed simultaneously, since they develop high titers of polyclonal IgE
(Ranger et al., 1998c). Dotted line indicates background optical density (OD) levels. Results are representative of three animals tested.
amounts of TNF-a and IFN-g (Ranger et al., 1998b;Yoshida animals developed significant B cell hyperactivation
(Schuh et al., 1997), but in those studies mature, acti-et al., 1998).
Surprisingly little previous work has identified the vated B cells were involved in the face of a strong Th2-
functional roles for NFATs in B cells, but the present
results strongly implicate an essential role for NFATs in Table 3. Anti-IL-4 Treatment of DKO Chimeras
B cell homeostasis. While previous studies have demon-
Treatment IgG1 IgEstrated the B cell receptor–mediated activation of NFAT
proteins (Choi et al., 1994; Venkataraman et al., 1994), Rat IgG 345 1220
Rat IgG 305 3000and several regulatory pathways have begun to be eluci-
Anti-IL-4 290 1000dated in B cells (Goitsuka et al., 1998; Gold et al., 1999;
Anti-IL-4 320 4400Yankee et al., 1999; Lemay et al., 2000; Marshall et al.,
Sera were assayed by ELISA in DKO chimeras treated with anti-2000), most of the B cell phenotypes seen in NFAT mu-
IL-4 or control rat IgG antibody, 5 mg intravenously weekly from 3tant animals have been attributed to secondary effects
to 10 weeks postreconstitution. Values indicate serum concentra-of the T cell abnormalities (Schuh et al., 1997; Ranger
tions in mg/mL.
et al., 1998c). Indeed, some strains of NFATc2-deficient
Immunity
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Figure 4. Plasma Cell Infiltration in End Organs of DKO Chimeras
(A) Routine histopathology of (a and d) kidney, (b and e) liver, and (c and f) lung from representative DKO (a–c) or wild-type (d–f) chimeras,
each 24 weeks postreconstitution. a–e, Congo red-hematoxalyn; f, hematoxalyn-eosin. Scale bar, 500 mm.
(B) Magnified views of representative plasma cell infiltrates. (a) A representative kidney infiltrate demonstrates multiple plasma cells with
typical eccentric nuclei. Arrows indicate some typical specimens. (b) Methyl-pyronin green staining of a liver infiltrate for plasma cells, staining
all infiltrating cells. Scale bar, 100 mm. These results are representative of three animals examined histologically.
predominant T cell response, while in the present study mechanisms like IL-4. The present findings conse-
quently indicate that NFAT proteins play a critical roleterminally differentiated plasma cells severely infiltrated
end organs in the absence of significant T cell effector in the intrinsic homeostasis of B cells, independent of
T and B Cells without NFATc1 and NFATc2
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CD3 stimulation after 48 hr, maintained for 7–10 days in mediumtheir role in T cell activation and effector function. The
containing 100 U/mL human IL-2, and then restimulated at 105 cells/specific mechanisms by which they enforce such ef-
well with plate-bound anti-CD3 in the absence of IL-2. Supernatantsfects, however, remain to be determined.
were harvested at 24, 48, or 72 hr after primary and secondary
stimulation.
Experimental Procedures B cell function was determined in a fashion analogous to T cells,
using populations enriched by magnetic sorting, using positive
Mice and Chimeras B2201 selection or negative Thy-11/CD41/CD81 selection. Twenty
NFATc11/2 (Ranger et al., 1998a, 1998b), NFATc22/2 (Hodge et al., thousand cells were incubated per well in 96-well plates in the
1996), and RAG-22/2 (Taconic, Germantown, NY) animals were main- presence or absence of mouse IL-4 (PeproTech, Inc., Rocky Hill,
tained on the BALB/c (H-2d) background. These mutations have NJ) and/or antibodies to CD40 (HM40-3, Pharmingen), CD154/CD40
been previously demonstrated to produce null NFAT isoforms that ligand (MR1, Pharmingen), IL-4 (BVD4-1D11, Pharmingen), IL-13
lack DNA binding activity (Hodge et al., 1996; Ranger et al., 1998b). (R&D Systems, Minneapolis, MD), or IgM. Supernatants were har-
Because NFATc1 deficiency causes embryonic lethality due to a vested at 24, 48, and 72 hr for immunoglobulin isotype analysis.
cardiac developmental defect, studies involving NFATc1-deficient
lymphoid systems require analysis in RAG-2 blastocyst complemen-
Induction of CD154 and CD95 Ligand on T Cellstation or fetal liver chimeras (de la Pompa et al., 1998; Ranger et
Expression of CD154 and CD95 ligand was induced by routine Tal., 1998a, 1998b; Yoshida et al., 1998). Chimeras from NFATc12/2
cell stimulation by concanavalin A or anti-CD3. Briefly, for CD154,NFATc22/2 fetal livers were established by a method described
whole splenocytes were incubated in DMEM with 10% FCS and 5previously (Ranger et al., 1998b): briefly, 5–10 3 106 fetal liver cells
mg/mL of concanavalin A (ConA; Sigma) for 6 hr. Cells were thenfrom E12-E14 NFATc12/2 NFATc22/2 embryos were transferred
harvested and stained for CD4 and CD154 expression as outlinedretro-orbitally or intravenously into 900 rad-irradiated RAG-2-defi-
above. For CD95 ligand, splenocytes first underwent 3–5 days ofcient BALB/c animals. When indicated, anti-IL-4 treatment was ad-
primary stimulation via 5 mg/mL ConA or via incubation on platesministered as weekly injections of 5–10 mg of the BVD4-1D11.2
previously coated with 1 mg/mL anti-CD3 and anti-CD28 antibodiesantibody (rat IgG1, a kind gift of Fred Finkelman, Cincinnati, OH)
and supplemented with 100 U/mL human IL-2. Cells were thenor control Rat IgG (ICN Pharmaceuticals, Inc., Costa Mesa, CA),
rested for 3–5 days in DMEM with 10% FCS and 100 U/mL IL-2 andbeginning 3 weeks postreconstitution.
then restimulated on anti-CD3/CD28 coated plates for 6 hr beforeTo confirm the viability of fetal liver chimerization as a technique
harvesting and fluorescent antibody staining.for the present study, chimeras were also made from singly deficient
NFATc12/2 or NFATc22/2 fetal livers (S. L. P., A. J. G., and A. M. R.,
Allogeneic Cytotoxicity Assayunpublished data). Chimeras bearing NFATc12/2 lymphoid cells
Cytotoxic capacity was assayed via an allogeneic system, usingdemonstrated modestly impaired T cell and B cell activation, includ-
EL4 (H-2b; American Type Culture Collection, Manassas, VA) cellsing reduced production of IL-4 and IL-4-dependent immunoglobulin
as targets. Briefly, precursor cytotoxic lymphocytes (H-2d in theisotypes, akin to prior studies using RAG-deficient blastocyst com-
present BALB/c background animals) were prepared and activatedplementation (Ranger et al., 1998b; Yoshida et al., 1998). Conversely,
from whole splenocytes incubated in DMEM with 10% FCS and 5chimeras bearing NFATc22/2 lymphoid cells demonstrated modestly
mg/mL ConA for 5 days, in the presence or absence of supplementalaccentuated T and B cell responses, including dysregulated produc-
100 U/mL human IL-2. The activated effector cells were then incu-tion of IL-4 and IL-4-dependent immunoglobulin isotypes, similar to
bated with 1 3 105 EL4 cells at varying effector:target ratios for 4prior studies using NFATc2-deficient animals (Hodge et al., 1996;
hr and assayed for cytolysis with a lactate dehydrogenase release-Xanthoudakis et al., 1996). We therefore conclude this method of
based assay (Cytotox 96, Promega Corp., Madison, WI).fetal liver chimerization in RAG-deficient hosts recapitulates the
phenotype of the murine lymphoid system in vivo.
Cytokine and Immunoglobulin Analyses
T cell supernatants were assayed for cytokine content by sandwichFlow Cytometry
ELISAs for respective cytokines (Pharmingen). Sera or B cell super-Single-cell suspensions from various lymphoid organs or peripheral
natants were similarly assayed for immunoglobulin isotype contentblood were analyzed by typical methods using FITC-, PE-, or Cy-
by ELISA (Southern Biotechnology Associates, Inc., Birmingham,Chrome-conjugated antibodies (BD Pharmingen, San Diego, CA),
AL) (Ranger et al., 1998c).a FACScan flow cytometer, and CellQuest 3.1 software (Becton,
Dickinson and Co., Franklin Lakes, NJ). Briefly, samples were col-
lected in complete Dulbecco’s modified Eagle medium (DMEM; Life Histopathology
Technologies, Inc., Rockville, MD) with 10% heat-inactivated fetal Animal organs at necropsy were fixed in OmniFix II (An-Con Genet-
calf serum (FCS; Mediatech, Inc., Herndon, VA) and cleared of eryth- ics, Inc., Melville, NY) or 10% buffered formalin (Baxter, Deerfield,
rocytes by osmotic lysis. Washed cells were then incubated with IL) and processed by typical histopathological procedures.
appropriate antibodies at 08C for 30–60 min, washed, and analyzed
live by flow cytometry. Antibodies included specificities toward CD3 Acknowledgments
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